Pfizer expects adjusted per-share earnings of $2.80 to $3 next year, below analysts’ consensus estimate of $3.06, according to FactSet. Revenue is expected to total $59.5 billion to $62.5 billion, ...

The company reiterated its 2025 adjusted earnings guidance of $3 to $3.15 a share. It guided for 2025 revenue of $62 billion, compared with its previous forecast of $61 billion to $64 billion.

Pfizer last month closed its up to $10bn (€8.5bn) acquisition of Metsera after winning shareholder approval, gaining a ...

FDA Commissioner Marty Makary defends agency leadership in NPR interview; New long COVID-19 research links disease to chronic ...

Pregnant people who received a COVID-19 vaccine were far less likely to experience severe illness or deliver their babies prematurely, according to a major new UBC-led study published in JAMA.

The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...

FDA Commissioner Martin Makary discusses vaccine policy, COVID-era decisions and the erosion of trust in government health ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, ...

The U.S. Food and Drug Administration has no plans to put a "black box" warning on COVID-19 vaccines, Bloomberg News reported ...

Budweiser is rewarding those ages 21 and older who have received the COVID-19 vaccine with a free round of beer.

Multivariable analyses confirmed that vaccination remained associated with lower hospitalization risk in both periods after controlling for comorbid conditions. Compared with vaccinated patients, the ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...